Fingerprint
Dive into the research topics of 'LateTIME: A Phase-II, randomized, double-blinded, placebo-controlled, pilot trial evaluating the safety and effect of administration of bone marrow mononuclear cells 2 to 3 weeks after acute myocardial infarction'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically